Publications - 2012
cea Rapport - 25 enregistrement(s) Update / Mise à jour : 27/11/2012 - BioDoc
Results / Résultats : 25
Chaumeil M M, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi A C, Carlier P, Lebon V. (2012).
pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 32: 771-779. IF:05.008 (Article) [I2BM/Mircen] Lien vers le web
Deglon N, Ruiz M, Drouet V, Zala D, Feyeux M, Auregan G, Hassig R, Dufour N, Perrier A, Saudou F, Hantraye P. (2012).
Allele-Specific Silencing of Mutant Huntingtin in HD Neural Stem Cells and In Vivo [meeting abstract].
MOLECULAR THERAPY 20: S30-S30. IF:06.873 (Meeting Abstract) [I2BM/Mircen]
Diou O, Tsapis N, Giraudeau C, Valette J, Gueutin C, Bourasset F, Zanna S, Vauthier C, Fattal E. (2012).
Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by (FMRI)-F-19
Biomaterials 33: 5593-5602. IF:07.404 (Article) [I2BM/Mircen] Lien vers le web
Feyeux M, Bourgois-Rocha F, Redfern A, Giles P, Lefort N, Aubert S, Bonnefond C, Bugi A, Ruiz M, Deglon N, Jones L, Peschanski M, Allen ND, Perrier AL. (2012).
Early transcriptional changes linked to naturally occurring Huntingtons disease mutations in neural derivatives of human embryonic stem cells
Hum. Mol. Genet. 21: 3883-3895. IF:07.636 (Article) [I2BM/Mircen] Lien vers le web
Galvan L, Lepejova N, Gaillard M C, Malgorn C, Guillermier M, Houitte D, Bonvento G, Petit F, Dufour N, Hery P, Gerard M, Elalouf J M, Deglon N, Brouillet E, de Chaldee M. (2012).
Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo.
Neurobiol Aging sous presse: IF:06.189 [I2BM/Mircen iBiTec-S/SBIGeM] Lien vers le web
Giraudeau C, Djemai B, Ghaly M A, Boumezbeur F, Meriaux S, Robert P, Port M, Robic C, Le Bihan D, Lethimonnier F, Valette J. (2012).
High sensitivity 19F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleen.
NMR IN BIOMEDICINE 25: 654-660. IF:03.214 (Article) [I2BM/Neurospin I2BM/Mircen] Lien vers le web
Gobbo OL, Petit F, Gurden H, Dhenain M. (2012).
In vivo detection of excitotoxicity by manganese-enhanced MRI: Comparison with physiological stimulation
Magn. Reson. Med. 68: 234-240. IF:02.964 (Article) [I2BM/Mircen I2BM/Neurospin] Lien vers le web
Jarraya M, Quijano-Roy S, Monnier N, Behin A, Avila-Smirnov D, Romero NB, Allamand V, Richard P, Barois A, May A, Estournet B, Mercuri E, Carlier PG, Carlier RY. (2012).
Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations
Neuromusc. Disord. 22: S137-S147. IF:02.797 (Article) [I2BM/Mircen] Lien vers le web
Kraska A, Santin MD, Dorieux O, Joseph-Mathurin N, Bourrin E, Petit F, Jan C, Chaigneau M, Hantraye P, Lestage P, Dhenain M. (2012).
In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin
PLoS ONE 7: -. IF:04.092 (Article) [I2BM/Mircen] Lien vers le web
de Langavant LC, Trinkler I, Remy P, Thirioux B, McIntyre J, Berthoz A, Dupoux E, Bachoud-Levi AC. (2012).
Viewing another person's body as a target object: A behavioural and PET study of pointing
Neuropsychologia 50: 1801-1813. IF:03.636 (Article) [I2BM/SHFJ I2BM/Mircen] Lien vers le web
Languille S, Blanc S, Blin O, Canale C I, Dal-Pan A, Devau G, Dhenain M, Dorieux O, Epelbaum J, Gomez D, Hardy I, Henry P Y, Irving E A, Marchal J, Mestre-Frances N, Perret M, Picq J L, Pifferi F, Rahman A, Schenker E, Terrien J, Thery M, Verdier J M, Aujard F. (2012).
The grey mouse lemur: A non-human primate model for ageing studies.
AGEING RESEARCH REVIEWS sous presse: IF:06.174 (Review) [I2BM/Mircen] Lien vers le web
Lavisse S, Guillermier M, Herard AS, Petit F, Delahaye M, Van Camp N, Ben Haim L, Lebon V, Remy P, Dolle F, Delzescaux T, Bonvento G, Hantraye P, Escartin C. (2012).
Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging
J. Neurosci. 32: 10809-10818. IF:07.115 (Article) [I2BM/Mircen I2BM/SHFJ] Lien vers le web
Martin C, Houitte D, Guillermier M, Petit F, Bonvento G, Gurden H. (2012).
Alteration of sensory-evoked metabolic and oscillatory activities in the olfactory bulb of GLAST-deficient mice.
FRONTIERS IN NEURAL CIRCUITS 6: 12. IF:05.098 (Article) [I2BM/Mircen] Lien vers le web
Mochel F, Durant B, Meng X L, O'Callaghan J, Yu H, Brouillet E, Wheeler V C, Humbert S, Schiffmann R, Durr A. (2012).
Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models.
J Biol Chem 287: 1361-1370. IF:04.773 (Article) [I2BM/Mircen] Lien vers le web
Mochel F, N'Guyen TM, Deelchand D, Rinaldi D, Valabregue R, Wary C, Carlier PG, Durr A, Henry PG. (2012).
Abnormal response to cortical activation in early stages of Huntington disease
Mov. Disord. 27: 907-910. IF:04.505 (Article) [I2BM/Mircen] Lien vers le web
Palfi S, Watts C, Gurrachaga J M, Buttery P, Ralph S, Deeley S, Lepetit H, Miskin J, Iwamuro H, Lavisse S, Kas A, Ramelli A L, Tani N, Dolphin P, Abhay K, Gabriel I, Fenelon G, Brugiere P, Naylor S, Hantraye P, Remy P, Barker R, Mitrophanous K. (2012).
ProSavin (R) a Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial Update.
MOLECULAR THERAPY 20: S23-S23. IF:06.873 (Meeting Abstract) [I2BM/Mircen]
Petiet A, Santin M, Bertrand A, Wiggins C J, Petit F, Houitte D, Hantraye P, Benavides J, Debeir T, Rooney T, Dhenain M. (2012).
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Neurobiol Aging 33: 1533–1544. IF:06.189 (Article) [I2BM/Mircen I2BM/Neurospin] Lien vers le web
Picq J L, Aujard F, Volk A, Dhenain M. (2012).
Age-related cerebral atrophy in nonhuman primates predicts cognitive impairments.
NEUROBIOLOGY OF AGING 33: 1096-1109. IF:06.189 (Article) [I2BM/Mircen I2BM/Neurospin] Lien vers le web
Poglio S, Gerby B, Deswarte C, Bauchet AL, Lewandowski D, Gauthier L, Leblanc T, Baruchel A, Soulier J, Ballerini P, Pflumio F. (2012).
CD34 EXPRESSION ON T-ALL PATIENTS CAN DISCRIMINATE DISTINCT CLONES WITH DIFFERENT AGGRESSIVENESS
Exp. Hematol. 40: S143-S143. IF:02.905 (Meeting Abstract) [iRCM/SCSR I2BM/Mircen]
Quijano-Roy S, Avila-Smirnow D, Carlier RY. (2012).
Whole body muscle MRI protocol: Pattern recognition in early onset NM disorders
Neuromusc. Disord. 22: S68-S84. IF:02.797 (Article) [I2BM/Mircen] Lien vers le web
Ruiz M, Deglon N. (2012).
Viral-mediated overexpression of mutant huntingtin to model HD in various species.
Neurobiol Dis 48: 202-211. IF:05,403 (Review) [I2BM/Mircen] Lien vers le web
de Sousa P L, Vignaud A, Araujo E C D, Carlier P G. (2012).
Factors controlling T2 mapping from partially spoiled SSFP sequence: Optimization for skeletal muscle characterization.
Magn. Reson. Med. 67: 1379-1390. IF:02.964 (Article) [I2BM/Mircen] Lien vers le web
Thibaud JL, Azzabou N, Barthelemy I, Fleury S, Cabrol L, Blot S, Carlier PG. (2012).
Comprehensive longitudinal characterization of canine muscular dystrophy by serial NMR imaging of GRMD dogs
Neuromusc. Disord. 22: S85-S99. IF:02.797 (Article) [I2BM/Mircen] Lien vers le web
Verhoeyen E, Relouzat F, Cambot M, Costa C, Negre D, Legrand F, Joubert C, Le Grand R, Cosset FL, Leboulch P, Dubart-Kupperschmitt A, Prost S. (2012).
Stem Cell Factor-Displaying Simian Immunodeficiency Viral Vectors Together with a Low Conditioning Regimen Allow for Long-Term Engraftment of Gene-Marked Autologous Hematopoietic Stem Cells in Macaques
Hum. Gene Ther. 23: 754-768. IF:04.218 (Article) [iMETI/STI iMETI/SIV I2BM/Mircen] Lien vers le web
Wary C, Naulet T, Thibaud JL, Monnet A, Blot S, Carlier PG. (2012).
Splitting of Pi and other 31P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy
NMR Biomed. 25: 1160-1169. IF:03.214 (Article) [I2BM/Mircen] Lien vers le web